Forest Investigative Site 0962 — Nashville, Tennessee

Forest Investigative Site 0962 is a clinical research site located in Nashville, Tennessee, United States 37232-2650.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Forest Investigative Site 0962 has participated in 2 clinical trials.

Therapeutic areas: Pulmonary Disease, Chronic Obstructive, Chronic Obstructive Pulmonary Disease.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 0962?

Forest Investigative Site 0962 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 0962 conducted?

Forest Investigative Site 0962 has 2 clinical trials on record. Their work covers Pulmonary Disease, Chronic Obstructive, Chronic Obstructive Pulmonary Disease.

Is Forest Investigative Site 0962 accredited by Crixeo Health?

Forest Investigative Site 0962 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 0962?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.